Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
ne ne ne ne ne ne ne
Author: Teri Moser Woo and Wendy L. Wright
ne ne ne ne ne ne ne
, TABLE OF CONTENT ne ne
Chapter ne 1. ne The Role of the Advanced Practice Nurse as Prescriber ...................................................4
ne ne ne ne ne ne ne ne
Chapter ne 2. n e Review of Basic Principles of Pharmacology ........................................................................5
ne ne ne n e ne
Chapter ne 3. ne Rational Drug Selection ............................................................................................................. 11
ne ne
Chapter ne 4. ne Legal and Professional Issues in Prescribing ....................................................................... 14
n e ne n e ne ne
Chapter ne 5. ne Adverse Drug Reactions ............................................................................................................ 16
ne n e
Chapter ne 6. ne An Introduction to Pharmacogenomics.................................................................................... 19
ne ne ne
Chapter ne 7. n e Nutrition and Nutraceuticals ...................................................................................................... 22
ne n e
Chapter ne 8. ne Herbal Therapies .......................................................................................................................... 28
ne
Chapter 9. Cannabis ........................................................................................................................................ 31
ne n e
Chapter 10. Pharmacoeconomics .................................................................................................................... 35
ne n e
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................. 38
ne ne ne ne ne ne ne
Chapter 12. Drugs Affecting the Central Nervous System.................................................................... 45
ne ne ne ne ne ne ne
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................. 53
ne ne ne ne ne ne ne ne
Chapter 14. Drugs Affecting the Respiratory System ............................................................................. 61
ne ne ne ne ne ne
Chapter 15. Drugs Affecting the Hematological System......................................................................... 65
ne ne ne ne ne ne
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ........................ 69
ne ne ne ne ne ne ne ne n e
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................... 75
ne ne ne ne ne ne n e
Chapter 18. Drugs Affecting the Gastrointestinal System ....................................................................... 77
ne ne ne ne ne ne
Chapter ne 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs.. 80
ne ne ne ne ne ne ne ne ne ne
Chapter ne 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ....... 83
ne ne ne ne ne ne ne ne ne ne
Chapter ne 21. Drugs Affecting the Reproductive System .......................................................................... 86
ne ne ne ne ne
Chapter ne 22. Drugs Affecting the Bones and Joints ............................................................................... 92
ne ne ne ne ne ne
Chapter ne 23. Drugs Affecting the Integumentary System ......................................................................... 96
ne ne ne ne ne
Chapter ne 24. Drugs Used to Treat Bacterial Infections..........................................................................101
ne ne ne ne ne n e
Chapter ne 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections.....................................105
ne ne ne ne ne ne ne ne n e
Chapter ne 26. Drugs Used to Treat Inflammatory Processes ...................................................................108
ne ne ne ne n e ne
Chapter 27. Drugs Used to Treat Eye and Ear Disorders.................................................................111
ne ne n e ne ne n e ne ne ne
Chapter 28. Anemia .......................................................................................................................................113
ne n e
Chapter 29. Anxiety and Depression..........................................................................................................116
ne ne ne ne
Chapter ne 30. ne Attention Deficit-Hyperactivity Disorder ...............................................................................120
ne n e
Chapter ne 31. n e Asthma and Allergy................................................................................................................122
ne n e
Chapter ne 32. ne Chronic Obstructive Pulmonary Disease ..............................................................................125
ne ne ne
Chapter ne 33. n e Contraception..............................................................................................................................127
Chapter ne 34. ne COVID-19: Acute and Chronic ............................................................................................130
ne ne ne
Chapter ne 35. ne Dermatological Conditions .......................................................................................................134
n e
Chapter ne 36. ne Diabetes Management ..............................................................................................................138
ne
Chapter ne 37. n e Gastroesophageal Reflux and Peptic Ulcer Disease .........................................................146
ne ne ne ne ne
Chapter ne 38. n e Headaches ...................................................................................................................................149
Chapter 39. Heart Failure .............................................................................................................................153
ne ne ne
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ................................................158
ne ne ne ne ne ne ne
Chapter 41. Menopausal Hormone Therapy ..............................................................................................161
ne ne ne n e
,Chapter 42. Hyperlipidemia ...........................................................................................................................164
ne n e
Chapter 43. Hypertension ...............................................................................................................................169
ne n e
Chapter 44. Hyperthyroidism and Hypothyroidism ...................................................................................174
ne n e ne ne
Chapter 45. Obesity........................................................................................................................................177
ne n e
Chapter 46. Pain Management: Acute and Chronic Pain .....................................................................181
ne ne ne ne ne ne ne
Chapter 47. Pneumonia ..................................................................................................................................185
ne n e
Chapter 48. Sexually Transmitted Diseases and Vaginitis .....................................................................187
ne ne ne ne ne ne
Chapter 49. Substance Use Disorders.........................................................................................................190
ne ne ne ne
Chapter 50. Tuberculosis................................................................................................................................195
ne n e
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa
ne ne ne ne ne ne ne ne ne ne ne ne
............................................................................................................................................................................197
Chapter 52. Urinary Tract Infections .........................................................................................................200
ne ne ne ne
Chapter 53. Women as Patients..................................................................................................................203
ne ne ne ne
Chapter 54. Men as Patients .......................................................................................................................207
ne ne ne n e
Chapter 55. Pediatric Patients .......................................................................................................................209
ne ne ne
Chapter 57. Geriatric Patients .......................................................................................................................213
ne ne ne
, Woo 1
Pharmacotherapeutics for APN ne ne Ch01
Prescribers,
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
ne ne ne ne ne ne ne ne ne ne
MULTIPLE CHOICE ne
1. Nurse practitioner prescriptive authority is regulated by:
ne ne ne ne ne ne
A. The National Council of State Boards of Nursing
ne ne ne ne ne ne ne
B. The U.S. Drug Enforcement Administration
ne n e ne ne
C. The State Board of Nursing for each state
ne ne ne ne ne ne ne
D. The State Board of Pharmacy
ne ne n e ne
ANS: C PTS: 1
2. The benefits to the patient of having an advanced practice registered nurse
ne ne ne ne ne ne ne ne ne ne ne
(APRN) prescriber include:
ne ne ne
A. Nurses know more about pharmacology than other prescribers because they
ne ne ne ne ne ne ne ne ne
take it both in their basic nursing program and in their APRN
ne ne n e n e n e n e n e n e n e n e n e n e
program.
n e
B. Nurses care for the patient from a holistic approach and include the
ne ne ne ne ne ne ne ne ne ne ne
patient in decision-making regarding their care.
ne ne ne ne ne ne
C. APRNs are less likely to prescribe narcotics and other controlled substances.
ne ne ne ne ne ne ne ne ne ne
D. APRNs are able to prescribe independently in all states, whereas a
ne ne ne ne ne ne ne ne ne ne
physician’s assistant needs to have a physician supervising their practice.
ne ne ne ne ne ne ne n e ne
ANS: B PTS: 1
3. Clinical judgment in prescribing includes:
ne ne ne ne
A. Factoring in the cost to the patient of the medication prescribed
ne ne ne ne ne ne ne ne ne n e
B. Always prescribing the newest medication available for the disease process
ne n e ne ne ne ne ne ne ne
C. Handing out drug samples to poor patients
ne ne ne ne ne ne
D. Prescribing all generic medications to cut costs ne ne ne ne ne ne
ANS: A PTS: 1
4. The process for choosing an effective drug for a disorder includes:
ne ne ne ne n e ne ne ne ne ne
A. Asking the patient what drug they think would work best for them
ne ne ne n e ne n e ne ne n e n e ne
B. Consulting nationally recognized guidelines for disease management
ne ne ne ne ne ne
C. Prescribing medications that are available as samples before writing a prescription
ne ne ne ne ne ne ne ne ne ne
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
ne ne ne ne ne ne ne
ANS: B PTS: 1
5. Nonintentional nonadherence of drug therapy may occur due to:
ne ne ne ne ne ne ne ne
A. Belief that medication does not work
ne ne ne ne ne
B. Adverse drug reactions ne ne
C. Chronic conditions that require daily therapy
ne n e ne ne ne
D. Forgetfulness or distraction ne ne
ANS: D PTS: 1